THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kenichi Tanaka to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Kenichi Tanaka has written about Antibodies, Bispecific.
Kenichi Tanaka
Connection Strength
0.781
Antibodies, Bispecific
  1. In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients. Haemophilia. 2022 Jan; 28(1):183-190.
    View in: PubMed
    Score: 0.781
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES